特拉多克健康公司(Teladoc Health Inc.)最新财报显示,截至9月30日的季度营收达到6.4051亿美元,同比下降3%,较分析师预期略有好转。该公司调整后每股亏损为19美分,优于分析师平均预期的28美分亏损。
尽管公司股价当季下跌2.8%,今年迄今也累计下跌了58.6%,但这份财报数据表现相对不错,尤其是每股亏损小于预期,可能是导致其股价在夜盘大涨11.85%的主要原因。
不过,需要指出的是,分析师目前对该公司股票的平均评级为"持有",看法较为谨慎。医疗设施与服务同行的平均评级也是"持有"。华尔街对特拉多克健康公司的12个月目标价中位数为10美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.